Japan Chemical Daily

Japan's leading chemical industry newspaper

Log In

Tokyo Institute of Technology, Kanto Chemical Develop Growth Medium for iPS Cell-Derived Small Intestine Models

Filed Under: Pharma Tagged With: , , , , ,

Kanto Chemical Co. Inc. has formed a research team with Shoen Kume, a professor at the Tokyo Institute of Technology’s…...

Please subscribe to read the full story.

Subscribe Free Trial

Related Articles:

Mitsubishi Chemical to Produce Regenerative Medicine Materials From Plants
Mitsubishi Chemical to Produce Regenerative Medicine…
Tosoh Enables Simple Removal of Regenerative Medicine Cells Using New Thermoresponsive Polymer
Tosoh Enables Simple Removal of Regenerative Medicine Cells…
JSR Set to Offer Pre-Clinical Trial Services Using Cancer Organoids in Japan
JSR Set to Offer Pre-Clinical Trial Services Using Cancer…
Tokyo Tech Devises a New Generation of BPA for Use in Chemical Surgery
Tokyo Tech Devises a New Generation of BPA for Use in…
Tokyo Tech Works on New Form of Photodynamic Cancer Treatment
Tokyo Tech Works on New Form of Photodynamic Cancer…
Menard, Mandom Expand Cosmetics Research to Look at Stem Cells
Menard, Mandom Expand Cosmetics Research to Look at Stem…